News

15 Dec 2017

Lowland extends its run of above average dividend increases

Lowland extends its run of above average dividend increases – Lowland’s NAV total return was 17.0% for the year ended 30 September 2017, compared with the benchmark All-Share Index return of 11.9%. Three interim dividends of 12.0p have been paid and a final dividend of 13.0p is proposed, total dividends for the year will amount to […]

15 Dec 2017

JPMorgan Indian loses out as HDFC foreign premium shrinks

JPMorgan Indian loses out as HDFC foreign premium shrinks – JPMorgan Indian Investment Trust says that, for the year ended 30th September 2017, the MSCI India Index (in sterling terms), returned +10.5%. The company produced a return on net assets of +9.0% over the year. However, the return to shareholders was ahead of the benchmark, […]

14 Dec 2017

F&C Commercial Property buys Bristol office

F&C Commercial Property buys Bristol office – F&C Commercial Property Holdings Limited, a subsidiary of F&C Commercial Property, has purchased a 56,059 sq ft prime office, One Cathedral Square, in Bristol for GBP33.5 million, reflecting a net initial yield of 5.0 per cent. The property is fully let to the strong covenants of the University of […]

14 Dec 2017

Finsbury Growth outperforms again

Finsbury Growth outperforms again – Finsbury Growth & Income Trust’s net asset value return per share for the year was 13.7% (2016: 20.6%) and the share price total return was 14.2% (2016: 20.8%). Both outperformed the benchmark, the All-Share Index, measured on a total return basis, which rose by 11.9%. The total dividend for the year […]

14 Dec 2017

Primary Healthcare Properties investing in Cork

Primary Healthcare Properties investing in Cork – Primary Health Properties ICAV, an Irish investment vehicle wholly owned by Primary Healthcare Properties, has agreed to acquire a large modern primary heathcare facility in County Cork, Ireland for a total cost of €20 million. The facility comprises a lettable area of circa 6,500m2 and will be fully let. […]

14 Dec 2017

GCP Infrastructure notes demand for dependable and predictable income

GCP Infrastructure notes demand for dependable and predictable income – GCP Infrastructure has announced results for the year ended 30 September 2017. The highlights are: Total shareholder return for the year of 2.6% and total return since IPO in 2010 of 97.8% NAV per ordinary share at 30 September 2017 of 110.57 pence (2016: 109.67 […]

13 Dec 2017

3i Infrastructure gets bid for Elenia

3i Infrastructure gets bid for Elenia – In a statement released on 12 December, 3i Infrastructure said “Further to recent speculation, the board of 3i Infrastructure plc confirms that bids have been received from potential acquirers of Elenia.  These bids are currently being considered by the company and the other shareholders in Elenia.  The company […]

12 Dec 2017

JPMorgan Chinese limiting Tencent and Alibaba exposure

JPMorgan Chinese limiting Tencent and Alibaba exposure – JPMorgan Chinese says that, for the year ended 30 September 2017, the company delivered a return to shareholders of +36.4%. This includes the final dividend of 1.6 pence paid in February 2017. The company’s total return on net assets was +28.5%; this return was just marginally behind the MSCI […]

12 Dec 2017

Baillie Gifford-favourite Alnylam completes key US filing

Baillie Gifford-favourite Alnylam completes key US filing US biotech star and Baillie Gifford stock pick Alnylam Pharmaceuticals has completed its US regulatory application for patisiran, a treatment of adults with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), putting the so-called RNA interference or “gene-silencing” therapeutic on track for approval in mid 2018.  Patisiran may become Alnylam’s first […]